Nucleus Presents its Psychedelic Series Featuring MAPS Founder and President Rick Doblin, Ph.D., and MAPS Israel CEO Keren Tzarfaty, Ph.D. at Soho Beach House Miami on Thursday, 2/29
Nucleus, a venture studio for psychedelics wholly owned by Iter Investments, will present its Psychedelic Series at Soho Beach House Miami on Thursday, February 29, at 7 p.m. Moderated by Iter Investments’ Managing Principal Dustin Robinson, Esq. CPA., the panel will feature Rick Doblin, Ph.D., and Keren Tzarfaty, Ph.D., where they will discuss the future of MDMA therapy.
Doblin is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). Doblin studied with renowned Psychiatrist Stanislav Grof, MD, Ph.D., and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. Doblin founded MAPS in 1986. MAPS is a nonprofit research and educational organization that develops medical, legal and cultural contexts, so people can benefit from the careful uses of psychedelics and marijuana. MAPS sees a world where psychedelics and marijuana are legally and safely used for peoples’ benefits.
Tzarfaty is the co-founder and CEO of MAPS Israel and leads psychedelic-assisted studies in Israel. She is a senior trainer and supervisor for MPBC and has been a clinical investigator in MPBC MDMA-assisted psychotherapy FDA-approved clinical studies. Tzarfaty is the co-founder of the Hakomi Institute of Israel, a Hakomi Trainer and one of the founders of the new MA program at Haifa University: Integrative Psychotherapy: Body, Mind, spirit. She holds an MA in Somatic Psychology and a Ph.D. in East-West Psychology.
Robinson is the managing principal of psychedelics venture capital firm Iter Investments; founding partner of psychedelics and cannabis law firm Mr. Cannabis Law; co-founder of psychedelics non profit Mr. Psychedelic Law; and co-founder of psychedelics data ecosystem Nucleus. He is a leader within the psychedelic ecosystem and has been ranked by Psychedelic Invest as the Top 100 Most Influential People in Psychedelics.
The psychedelic series was launched in 2021 by Robinson and visionary leader Sam Baum. The series features experts in the psychedelic space such as CEOs, doctors, lawyers and celebrities. The panel started at Soho Beach House Miami and over time has expanded to locations throughout the country including, New York, Chicago and California, as well as internationally in London and Amsterdam.
When:
Thursday, February 29, at 7 p.m. ET
Where:
Soho Beach House Miami
4385 Collins Ave., Miami Beach, FL 33140
How:
The event is private and only open to Soho House members.
EDITOR’S NOTE: Media is invited to attend the Psychedelic Series events. Please contact iter@dureeandcompany.com to RSVP. Limited space is available.
About Nucleus
Nucleus is a venture studio creating brands in the growing psychedelics industry. Nucleus has built 12 brands that bridge industry gaps in media, data, and technology. The data platform, Neuly, powers the ecosystem while Psychedelic Invest serves as a content network for those curious to learn more about the psychedelics industry. Nucleus has also developed a marketing platform, a directory of practitioners, and a blockchain protocol, to further support the many ways Nucleus can power the industry on its way to help millions of people find the right treatments, experiences, and overall well-being. For more information, visit withnucleus.com.
About Iter Investments
Iter Investments is an investment firm that deploys capital in and around the burgeoning psychedelic industry. Iter Investments invests with the mission of reimagining how the mental health and wellness industry delivers care. For more information, visit www.iterinvestments.com or email contact@iterinvestments.com.